The Marque The Marque
The Marque
About Services Profiles Press Contact
Jesus’ Profile > News Archive

Jesus’ News Archive

The News Archive for Jesus Mantas

Jesus’ News Archive

The News Archive for Jesus Mantas

Jesus Mantas

Global Managing Partner

IBM Services
New York, NY, USA
27 Feb 2020 | Business Wire

IBM Services and Announce Strategic Alliance for Digital Transformation With AI

“Businesses need to move beyond experimenting with limited-impact AI applications, constrained by quality and availability of data, and implement industrial strength, scaled deployments of mission critical AI applications that deliver impact at scale in months, not years,” said Jesus Mantas, Managing Partner, IBM Services.

29 Jan 2020

I.AM+ Aims to Accelerate Ethical AI Adoption with Red Hat OpenShift on IBM Public Cloud

Jesus Mantas, Managing Partner, IBM Services, says, "The combination of Omega with Red Hat OpenShift on IBM public cloud is designed to provide I.AM+ clients a faster way to add intuitive, context aware AI use cases to their business platforms, resulting in faster adoption and better experiences for customers." 

20 Jan 2020

Artificial Intelligence Toolkit Helps Companies Protect Society and Their Business

"Integrity, Ethics and risk management are boardroom matters which are directly impacted by AI", said Jesus Mantas, Senior Managing Partner at IBM and board member at Biogen Inc. "Board directors have a duty to provide oversight to the enhancements required to integrity principles, 'human in the loop' policies, and risk management frameworks to include the effect of AI algorithms becoming the norm in every operational aspect of corporations."

13 Nov 2019

C-Suite Study Finds Market Leaders Prioritize Trust

There’s no question that companies need to get a better handle on data...“But that is not sufficient unless each one of your stakeholders actually trusts the data you’re providing and what you’re doing with it,” says IBM Managing Partner Jesus Mantas.

29 Apr 2019

Biogen Announces Three New Nominees for Election to Board of Directors

Biogen today announced the nomination of John R. Chiminski, William A. Hawkins and Jesus B. Mantas to stand for election to the company’s board of directors at its 2019 annual meeting of stockholders, scheduled for June 19, 2019. “We are excited to announce the nomination of John, Bill and Jesus for election to Biogen’s Board. Their diverse backgrounds and experience in scientific, medical, and digital innovation are highly complementary to our pioneering vision,” said Michel Vounatsos, Biogen’s Chief Executive Officer.

Load More